A major multi-country study has found that WHO-recommended first-line antibiotics for neonatal sepsis are likely to be ...

II study, a prospective study investigating antibiotic use and clinical outcomes in newborns with sepsis in Pakistan, Nigeria ...

Discover more about the effectiveness of WHO-recommended first-line antibiotics for neonatal sepsis, according to new ...

Neonatal sepsis remains a critical challenge in neonatal care, representing one of the leading causes of morbidity and mortality, particularly in low‐ and middle‐income settings. Characterised by a ...

Sepsis leads to life-threatening organ failure due to dysregulated host responses to infection and presents uniquely across age groups. Neonatal sepsis, affecting infants in their first 28 days, ...

A genetic signature in newborns can predict neonatal sepsis before symptoms even start to show, according to a new study. The study, led by University of British Columbia and Simon Fraser University ...

Among the 981,869 children, 0.8% were diagnosed with sepsis and less than 0.1% diagnosed with meningitis; overall, 1.2% of children developed epilepsy during the study period. Children with clinically ...

A new study found that a multifaceted infection prevention and control intervention could at least temporarily thwart outbreaks of infections from the Klebsiella pneumoniae bacterium, a leading cause ...

Among the sample of 981,869 children, researchers found that the incidence rate of epilepsy was 1.6 and 0.9 per 1000 person-years for children with diagnosed sepsis and those without an infection, ...

Tuesday, 21 April 2026, Munich, Germany) A major multi-country study has found that WHO-recommended first-line antibiotics for neonatal sepsis are ...